|
Volumn 34, Issue 5, 2002, Pages 1614-1616
|
Preemptive therapy with plasmapheresis/intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive cross-match
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBODY;
HLA ANTIBODY;
HLA ANTIGEN CLASS 1;
HLA ANTIGEN CLASS 2;
IMMUNOGLOBULIN;
IMMUNOGLOBULIN G;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
METHYLPREDNISOLONE SODIUM SUCCINATE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
STEROID;
TACROLIMUS;
ALLOANTIBODY;
CREATININE;
ADULT;
AGED;
CLINICAL ARTICLE;
CONFERENCE PAPER;
CONTROLLED STUDY;
CYTOTOXICITY;
DIALYSIS;
FEMALE;
FLOW CYTOMETRY;
GRAFT FAILURE;
HLA MATCHING;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY DONOR;
KIDNEY TRANSPLANTATION;
MALE;
PLASMAPHERESIS;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
RISK FACTOR;
ARTICLE;
BLOOD;
FOLLOW UP;
HISTOCOMPATIBILITY TEST;
IMMUNOLOGY;
LIVING DONOR;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
PHYSIOLOGY;
RACE;
TIME;
UNITED STATES;
ADULT;
AGED;
COMBINED MODALITY THERAPY;
CREATININE;
FEMALE;
FOLLOW-UP STUDIES;
HISTOCOMPATIBILITY TESTING;
HUMAN;
IMMUNOGLOBULINS, INTRAVENOUS;
ISOANTIBODIES;
KIDNEY TRANSPLANTATION;
LIVING DONORS;
MALE;
MIDDLE AGE;
PLASMAPHERESIS;
RACIAL STOCKS;
RETROSPECTIVE STUDIES;
TACROLIMUS;
TIME FACTORS;
UNITED STATES;
CONTINENTAL POPULATION GROUPS;
HUMANS;
MIDDLE AGED;
|
EID: 0035993661
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)03044-0 Document Type: Conference Paper |
Times cited : (72)
|
References (9)
|